Daphne S Bakker (Daphne Bakker)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Atopic Dermatitis

Ejection Fraction

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Roselie E Achten, Judith L Thijs, M Marlot van der Wal, Chantal van Luijk, Daphne S Bakker, Edward F Knol, Matthijs van Luin, Mohsin El Amrani, Eveline Delemarre, Ahmed M I Elfiky, Joke de Boer, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2024)
Roselie Achten, Coco Dekkers, Daphne S Bakker, Chantal van Luijk, Marlies de Graaf, Femke van Wijk, Joke de Boer, Marjolein de Bruin-Weller, Judith Thijs
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Celeste M Boesjes, Madelon van Emst, Daphne S Bakker, Lotte S Spekhorst, Femke van Wijk, Marlies de Graaf, Marjolein S de Bruin-Weller
Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Roselie E Achten, Judith L Thijs, Marlot van der Wal, Chantal van Luijk, Marlies de Graaf, Daphne S Bakker, Joke de Boer, Femke van Wijk, Marjolein de Bruin-Weller
Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response, and conjunctival goblet cell analysis. Allergy (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (4) (2023)
Coco Dekkers, M Marlot van der Wal, Leonie van den Noort, Daphne S Bakker, Marjolein de Bruin-Weller, Femke Van Wijk
IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Celeste M Boesjes, Daphne S Bakker, Edward F Knol, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Roselie E Achten, Daphne S Bakker, Chantal M van Luijk, M Marlot van der Wal, Marlies de Graaf, Femke van Wijk, Nicolaas P A Zuithoff, Lisa P van der Rijst, Celeste M Boesjes, Judith L Thijs, Joke H de Boer, Marjolein de Bruin-Weller
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (6) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)
Esmé Kamphuis, Celeste M Boesjes, Laura Loman, Daphne S Bakker, Mila Poelhekken, Nicolaas P A Zuithoff, Marijke Kamsteeg, Geertruida L E Romeijn, Femke Van Wijk, Marjolein de Bruin-Weller, Marlies de Graaf, Marie-Louise A Schuttelaar
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 33 (12) (2022)
Lotte S Spekhorst, Daphne S Bakker, Julia Drylewicz, Theo Rispens, Floris Loeff, Celeste M Boesjes, Judith L Thijs, Geertruida L E Romeijn, Laura Loman, Marie-Louise Schuttelaar, Femke van Wijk, Marlies de Graaf, Marjolein de Bruin-Weller
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis. Allergy 77 (11) (2022)
Daphne S Bakker, José J M Ter Linde, Mojtaba M Amini, Lieneke F M Ariëns, Chantal M van Luijk, Marjolein de Bruin-Weller, Judith L Thijs, Yvonne Vercoulen, Femke van Wijk
Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study. Allergy 76 (12) (2021)
Daphne S Bakker, Lieneke F M Ariëns, Barbara Giovannone, Dirk-Jan Hijnen, Eveline M Delemarre, Edward Knol, Stefan Nierkens, Marjolein de Bruin-Weller, Judith L Thijs, Julia Drylewicz
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy 75 (12) (2020)